Roger Hajjar

1 week ago | cgtlive.com | Roger Hajjar |Noah Stansfield

A few years ago, Mass General Brigham established its Gene and Cell Therapy Institute (GCTI) with the goal of helping innovative preclinical research in the field make its way into first-in-human clinical trials. At the American Society of Gene & Cell Therapy (ASGCT) 28th Annual Meeting, held May 13 to 17, 2024, in New Orleans, the GCTI gave several presentations related to its mission.

3 weeks ago | cgtlive.com | Roger Hajjar |Noah Stansfield

“That's really been the mission and the differentiator for the Institute: to really bring together a set of platforms to help our investigators get to first-in-human [trials] because overall, the mission of the academic medical center that we're in is to help patients and to bring novel therapies to them.”Advanced modalities like gene therapy and cell therapy have attracted an enormous flurry of nonclinical and preclinical research activity in recent years.